N eutrophils stimulated with fMLP or a variety of other chemoattractants that couple to heterotrimeric G proteins exhibit rapid activation of a large number of protein kinases that participate in the functional responses of these cells. These protein kinases include two p21-activated protein kinases (Paks) 3 with molecular masses of 63 and 69 kDa (␥-and ␣-Pak; Refs. 1-5) and certain mitogen-activated protein kinase (MAPK) cascades (e.g., extracellular signal-regulated kinases (ERK-1/2), p38-MAPK; Refs. 6 -10) . Paks are Ser/Thr protein kinases that undergo autophosphorylation/activation upon interacting with the active (GTP-bound) forms of the small GTPases(p21) Rac or Cdc42 (11) . Activation of the Paks in neutrophils can be blocked by inhibitors of heterotrimeric G proteins (pertussis toxin) (2, 5) , phosphatidylinositol 3-kinase (PI 3-K; i.e., wortmannin, LY 294002) (12) , and tyrosine kinases (13, 14) . Paks or Pak-like kinases contain binding sites for the ␤␥-subunits of complex G proteins (15) , guanine nucleotide exchange factors (GEF; i.e., Pakinteracting exchange factors) (16) , and adaptor proteins (Nck) (17, 18) . Paks may directly interact with the cytoskeleton through p95 paxillin-kinase linker, which binds directly to both Pak-interacting exchange factors and the focal adhesion adaptor protein paxillin (19) . Thus, Paks may be capable of integrating messengers from a number of signal transduction pathways. Paks can participate in a broad range of cellular events that include rapid cytoskeletal responses, activation/potentiation of several distinct MAPK cascades and apoptosis (for review see Ref. 20 and 21) . Recent studies have implicated Pak in the activation of NF-B in macrophages (22) , tumor growth (23) and the pathogenesis of HIV (24, 25) . Paks can also catalyze the phosphorylation in vitro of both the 47-and 67-kDa subunits of the superoxide (O 2 Ϫ )-generating system of phagocytic leukocytes (NADPH-oxidase) (5, 26) . However, it is not known whether Paks participate in the phosphorylation of these oxidase subunits in vivo.
Recent studies have shown that heterotrimeric G proteins can activate Ras, Src family tyrosine kinases, and the extracellular signal regulated kinases (ERKs-1/2) through a variety of signal transduction pathways (27, 28) . One such pathway contains phosphatidylinositolspecific phospholipase C (PI-PLC) and the Ca 2ϩ /calmodulin (CaM) complex as major components in the activation of Src and Ras (28) . We have recently demonstrated that D-erythro-sphingosine blocks activation of the 63-and 69-kDa Paks in neutrophils if added to the cells either before or after stimulation with fMLP (29) . Interestingly, D-erythro-sphingosine can inhibit a number of enzymes activated by the Ca 2ϩ /CaM complex (30) . In this paper, we describe the effects of selective antagonists of PLC, the intracellular Ca 2ϩ channel, the Ca 2ϩ /CaM complex, and CaM-activated protein kinases (CaM-PK) on the activation of Paks in neutrophils. The data indicate that the Ca 2ϩ /CaM complex has a major role in regulating the Paks in these cells along with other enzyme systems activated by small GTPases. were purchased from Calbiochem (La Jolla, CA). Purified mouse mAbs to human Ras was obtained from PharMingen/Transduction Laboratories (San Diego, CA). A mouse mAb to full-length human Rac was purchased from Upstate Biotechnology (Lake Placid, NY). Affinity-purified, rabbit polyclonal Abs that recognized only the active (doubly phosphorylated) forms of MAP/ERK kinase (MEK)1 and MEK2 (phospho-MEK-1/2 (Ser 217 /Ser 221 ) Ab) were obtained from New England Biolabs (Beverly, MA). Affinity-purified, rabbit polyclonal Abs that recognized only the active (doubly phosphorylated) forms of ERK (p44/ERK1 and p42/ERK2) were obtained from Promega (Madison, WI). Affinity-purified rabbit polyclonal Abs that recognized both the phosphorylated and nonphosphorylated forms of ERK (p44/42 (ERK-1/2) MAPK Abs) were also purchased from New England Biolabs. Goat anti-rabbit IgG labeled with HRP, goat antimouse IgG labeled with HRP, a Super Signal substrate Western blotting kit for luminol-enhanced chemiluminescence, and an ImmunoPure binding/ elution buffer system for stripping and reblotting Western blots were purchased from Pierce (Rockford, IL). Sources of all other materials are described elsewhere (1-3).
Materials and Methods

Materials
N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide (W-7); N-(6-amino- hexyl)-1-naphthalenesulfonamide (W-5); N-(4-aminobutyl)-5-chloro-1-naphtha- lenesulfonamide (W-13); N-(4-aminobutyl)-1-naphthalenesulfonamide (W-12); 1-[6-((17␤-3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl]-1H-pyrrole-2,5-di-
Preparation of neutrophils
Guinea pig peritoneal neutrophils were prepared as described previously (31) . These preparations contained Ͼ90% neutrophils with viabilities always Ͼ90%.
Detection of renaturable protein kinases (Paks) in polyacrylamide gels
Paks and certain other protein kinases were detected directly in gels by their ability to undergo renaturation and catalyze the phosphorylation of a peptide substrate fixed within a gel that corresponds to amino acid residues 297-331 of the 47-kDa protein component of the phagocyte oxidase (p47-phox). This technique was performed as described elsewhere (2) except the amount of cells was reduced to 3 ϫ 10 6 /ml.
Detection of activated Rac and Ras
Activated forms of Rac or Ras were measured in neutrophil lysates by their ability to bind specifically to GST-fusion proteins containing the Cde42/ Rac interactive binding (CRIB) domain of Pak1b (crib domain, amino acid residues 56 -227) (GST-Pak-CRIB) or the Ras-binding domain of Raf (GST-Raf-RBD) coupled to glutathione agarose beads (32, 33) . The beads were subsequently isolated, washed, and subjected to SDS-PAGE as described previously (32, 33) . Specific binding of Rac to the GST-Pak crib fusion protein was determined by Western blotting with a specific Ab to this small GTPase. Conditions for Western blotting are described below. Fusion proteins were prepared as described previously (32, 34) .
Immunoblotting/detection of activated ERKs and MEK in stimulated neutrophils
Neutrophils (3 ϫ 10 6 /ml) were stimulated and lysed as described (1) . Aliquots of these samples were separated by SDS-PAGE (35 g/lane) on 9.0% (v/v) polyacrylamide slab gels and transferred electrophoretically to Immobilon-P membranes as described (1) . Activated ERK and MEK were assayed by Western blotting with Abs that recognized only the activated (doubly phosphorylated) forms of these kinases (35) . Activated kinases and the small GTPases were visualized with a luminol-enhanced chemiluminescence detection system (Pierce), which monitored the activity of HRP bound to the secondary Ab (35) . Membranes were incubated with the primary Ab against 1.0 g/ml Rac or Ras (1:500 dilution) for 1 h at room temperature. All other Ab dilutions and conditions for Western blotting are detailed by Huang et al. (14) .
In certain experiments (Fig. 6) , products of the chemiluminescence detection system were removed by washing the membranes two times (10 min/wash) with TBST (20 mM Tris-HCl (pH 7.4) containing 150 mM NaCl and 0.01% (v/v) Tween 20). These blots were then reprobed with a different Ab as described above so that both Ags could be visualized simultaneously (Ref. 35 ; Fig. 6 ). At the end of these experiments, both the immunodetection system and the bound Abs were removed from the blot by incubating the membranes with ImmunoPure elution buffer (Pierce) for 30 -60 min at room temperature followed by two washes with TBST. The blots were then stained with an Ab that recognized both the phosphorylated and nonphosphorylated forms of ERK to confirm that equal amounts of protein were present in each lane of the gel.
Miscellaneous procedures
O 2
Ϫ release from neutrophils was measured as described previously (2) .
Analysis of data
Unless otherwise noted, all of the autoradiographic observations were confirmed in at least three separate experiments performed on different cell preparations. The numbers of observations (n) are also based on different cell preparations.
Results
Effects of Ca 2ϩ /CaM antagonists on activation of the Paks in neutrophils
Neutrophils stimulated with the chemoattractant fMLP exhibit rapid activation of two Paks with molecular masses of ϳ63 and 69 kDa along with two unidentified renaturable protein kinases with masses of ϳ49 and 40 kDa ( Fig. 1 ; Refs. 2 and 4). These kinases can be detected directly in gels by their ability to undergo renaturation and catalyze the phosphorylation of a peptide substrate fixed within a gel. Positions of the protein kinases are visualized by autoradiography after exposure of the gel to [␥-32 P]ATP (2). The peptide used corresponds to amino acid residues 297-331 of p47-phox and contains several of the phosphorylation sites of this protein.
Certain naphthalenesulfonamides (W-7, W-13) have been designed as selective antagonists of CaM (36) . The order of potency of these compounds in vitro is W-7 Ͼ W-13 with the unchlorinated analogues of these molecules (W-5, W-12) being considerably less active (36) . Thus, W-5 and W-12 serve as excellent controls for evaluating nonspecific cellular effects of W-7 and W-13, respectively. Treatment of neutrophils with 50 M W-7 for 5.0 min before stimulation with 1.0 M fMLP completely blocked activation of the 63-and 69-kDa Paks along with the 49-and 40-kDa kinases (Fig. 1c) . In contrast, 50 M W-13 was only partially effective in blocking activation of these kinases and 50 M W-5 lacked activity (Fig. 1, d and e). Increasing the concentration of W-13 to 100 M markedly reduced activation of the 63-and 69-kDa Paks, whereas the unchlorinated derivative W-12 was inactive even at this concentration ( Fig. 1, f and g ). these drugs that blocked O 2 Ϫ release (Fig. 3) were very similar to those that inhibited activation of the 63-and 69-kDa Paks (Fig. 2) . In contrast, treatment of neutrophils with (50 -100 M) KN-93 for 15-30 min at 37°C before stimulation with 1.0 M fMLP had no effect on O 2 Ϫ release (n ϭ 4; data not shown) even though this antagonist was effective against Pak (Fig. 2D) .
Effects of Ca 2ϩ /CaM antagonists on the activation of Rac in stimulated neutrophils
The fact that a variety of antagonists of Ca 2ϩ signaling events were equally effective in blocking activation of the Paks and NADPHoxidase complex in neutrophils suggested that these inhibitors might be effecting a common component of these systems. As noted above, activated Rac (GTP-bound) can trigger autophosphorylation/activation of Pak (11) . Rac-GTP is also an obligatory subunit of the NADPH-oxidase system (43) . The effects of CaM antagonists on the activation of Rac in fMLP-stimulated neutrophils were examined with a fusion protein containing the p21-binding domain of Pak that binds only the GTP-bound form of Rac (33, 44, 45) . Rac exhibited maximal activation within 15 s of cell stimulation, followed by significant inactivation at 3.0 min (Fig.  4A ). This pattern of activation was virtually identical with that exhibited by the 63-and 69-kDa Paks in fMLP-stimulated neutrophils ( Fig. 4B; Refs. 2 and 4) . Incubation of neutrophils with 50 M W-7 or 15 M TFP for 5.0 min at 37°C before stimulation with 1.0 M fMLP for 15 s blocked activation of Rac, whereas 50 M W-5 or 15 M PMZ did not effect this process (Fig. 4C ). This treatment of neutrophils with W-7, W-5, TFP, and PMZ reduced activation of Rac by 91 Ϯ 5%, 9 Ϯ 10%, 97 Ϯ 5%, and 36 Ϯ 8% (SD, n ϭ 3), respectively. Treatment of neutrophils with 200 nM wortmannin for 10 min at 37°C before stimulation with 1.0 M fMLP for 15 s reduced the activation of Rac by 68 Ϯ 9% (range, n ϭ 2) (Fig. 2D) as reported in previous studies (33, 44) . In contrast, treatment of neutrophils with 50 M KN-93 for 30 min at 37°C before stimulation with 1.0 M fMLP for 15 s did not effect the activation of Rac (n ϭ 2; Fig. 2D ) .
Effects of Ca 2ϩ /CaM antagonists on the activation of Ras and the extracellular regulated kinases (ERKs) in neutrophils
Previous studies have shown that CaM antagonists can either block (27, 28) or prolong (46) the activation of ERKs in various cell types. Because ERKs are effector proteins for the small GTPase Ras, we examined the effects of CaM antagonists on the activation of Ras, MEK, and ERK in neutrophils (Figs. 5 and 6 ). Previous studies have shown that neutrophils stimulated with fMLP exhibit rapid activation of Ras (8) and ERK-1/2 (6 -10, 35). We confirmed the activation of Ras in guinea pig neutrophils stimulated with fMLP using a fusion protein that contained the Ras binding domain of Raf coupled to glutathione agarose beads. This fusion protein binds only the activated, GTP-bound form of Ras (32) . Ras exhibited maximal activation within 15-30 s followed by significant inactivation at 1.0 -3.0 min (Fig. 5A ). This activation of Ras was insensitive to 200 nM wortmannin (n ϭ 3; data not shown). Treatment of neutrophils with 50 M W-7 or 15 M TFP for 10 min before stimulation with 1.0 M fMLP for 30 s markedly reduced the activation of Ras, whereas compounds W-5 (50 M) and PMZ (15 M) had little or no effect on this reaction (Fig. 5B ). This treatment with 50 M W-7, 50 M W-5, 15 M TFP, or 15 M PMZ reduced the activation of Ras by 80 Ϯ 18%, 10 Ϯ 9%, 97 Ϯ 5%, and 16 Ϯ 27% (SD, n ϭ 3), respectively.
Activation of ERK-1/2 and MEK in neutrophils was monitored with Abs that recognized only the activated (doubly phosphorylated) forms of these kinases. p42-ERK, a small amount of p44-ERK, and MEK undergo a pronounced activation in neutrophils at ϳ1.0 -3.0 min after stimulation of these cells with fMLP (35) . Previous studies have shown that MEK-2 is the predominant isoform of this kinase in human neutrophils and undergoes activation in fMLP-stimulated cells (47) . Data presented in Fig. 6 demonstrate the effects of CaM antagonists on the activation of ERK-1/2 and MEK in neutrophils. The cells were incubated with the antagonists for 10 min at 37°C and then stimulated with 1.0 M fMLP for 3.0 min. A single blot was first stained for activated ERKs (Fig.  6A ) and then stained again for activated MEK (Fig. 6B) . As was the case with Ras, 50 M W-7 and 15 M TFP markedly reduced the activation of ERKs and MEK in these cells whereas 50 M W-5 and 15 M PMZ had little or no effect. Visualization of MEK by the chemiluminescence detection system required a longer reaction time than that needed for p42-ERK (Fig. 6A) , which resulted in the p42-ERK band being over-exposed in Fig. 6B . Treatment of the cells with 50 M W-7, 50 M W-5, 15 M TFP, and 15 M PMZ reduced the activation of p42-ERK by 96 Ϯ 4%, 21 Ϯ 10%, 100 Ϯ 0%, and 19 Ϯ 26% (n ϭ 2-3), respectively. These data were calculated by densitometry from blots stained for p42-ERK alone as shown in Fig. 6A . Thus, the Ca 2 /CaM complex plays a major role in activating the small GTPases Ras and Rac in neutrophils along with their downstream effectors (e.g., Paks, NAPDH-oxidase, ERKs).
Discussion
The overall pathway that triggers activation of Rac and Pak in neutrophils is largely unknown. Subunits of complex G proteins coupled to the fMLP receptor are involved in triggering activation of PI-PLC and PI 3-K in neutrophils (48 -51) . Inositol(1,4,5)-trisphosphate, a product of PI-PLC, promotes a transient increase in intracellular Ca 2ϩ in neutrophils by triggering the release of this cation from intracellular storage depots (48) . In this paper, we report that a variety of structurally diverse, selective antagonists of PLC, the intracellular Ca 2ϩ channel, CaM and CaM-PK block activation of the 63-and 69-kDa Paks. Antagonists of CaM were also found to block activation of Rac and Ras in neutrophils along with other downstream targets of these small GTPases. The significance of these and other novel observations are discussed below.
It is not possible to employ the techniques of molecular biology to investigate the involvement of the Ca 2ϩ /CaM complex in Pak activation in primary neutrophils because these cells are shortlived. Therefore, particular care was taken to employ structurally distinct antagonists, which blocked different stages in triggering the increase in cytosolic Ca 2 and the subsequent target/effector proteins. The choice was also restricted to those compounds for which less active analogues were available. The order of effectiveness of the CaM antagonists in blocking activation of Paks (i.e., TFP Ͼ W-7 Ͼ W-13 Ͼ PMZ, W-5, and W-12) (Figs. 1 and 2) was identical with that reported for CaM-dependent enzymes in vitro (39) . Although TFP and W-7 can also inhibit protein kinase C (PKC) at high concentrations (52), PKC is not involved in activating the Paks in neutrophils (1, 4, 5) . Moreover, the concentrations of TFP and W-7 required for blockade of Pak activation (i.e., ϳ10 and 25 M, respectively) (Fig. 2) were very similar to that observed for CaM-dependent processes (39) and severalfold less than that required to inhibit PKC (52) . The IC 50 values for TFP, W-7, W-5, and PMZ blocking the CaM mediated activation of cAMP phosphodiesterase in vitro are 2-10, 28, 240, and 200 -340 M, respectively (39) . The concentrations of TFP, W-7, U-73122, KN-93, and TMB-8 routinely used to block CaM, CaM, PLC, CaM-PK, and the intracellular Ca 2a channel in vivo are ϳ10, 35, 1.0, 20, and 100 -300 M, respectively (37) (38) (39) 42) . Each of these antagonists were effective at blocking activation of the Paks in neutrophils at these doses (Fig. 2) . In contrast, the antagonists W-7 (50 M) and TFP (15 M) did not effect the increases in 
Ca
2ϩ permeability or cytosolic Ca 2ϩ that occur in fMLP-stimulated neutrophils (Refs. 38 and 53; data not shown), which indicates that these inhibitors are selective for certain pathways and do not have a general disruptive effect on the fMLP-receptor.
The GEF that promotes activation of Rac (and hence Pak) in fMLP-stimulated neutrophils is blocked by antagonists of PI 3-K and tyrosine kinases (33, 44) . Only the ␥-isoform of PI 3-K is activated when neutrophils are stimulated with fMLP (49 -51) . Unlike other isoforms of PI 3-K, the ␥-isoform is directly activated by ␤␥-subunits of complex G proteins and is not activated by binding to tyrosine phosphorylated proteins (49 -51) . Thus, the tyrosine kinase involved in the activation of Rac is not likely to be "upstream" of PI 3-K. One possible explanation for these data is that the relevant GEF requires both products of PI 3-K and tyrosine phosphorylation for activation (Fig. 7) . Interestingly, Vav, a GEF for Rac, undergoes enhanced phosphorylation/activation by a Srcrelated kinase when bound to PIP 3 (54) . Location of Vav or a similar GEF upstream of Rac would account for the sensitivity of the Pak stimulatory pathway to pertussis toxin, wortmannin, and herbimycin.
How does CaM fit into the scenario described above? Although the answer to this question is not yet known, a modest amount of speculation may be appropriate here. Certain receptors coupled to pertussis-toxin-sensitive G proteins can trigger activation of Srcrelated tyrosine kinases, Ras and ERK through a stimulatory pathway that contains PI-PLC and CaM (27, 28) . Fig. 7 presents a modified portion of that model (28) . The ability of CaM antagonists to block activation of Ras and ERK in neutrophils (Figs. 5 and 6) is consistent with a similar stimulatory pathway being present in these cells. Addition of a GEF to this pathway, which is synergistically activated by PI 3-K and tyrosine phosphorylation as described above, will account for all of the data presented herein and in earlier publications (2) (3) (4) (5) (12) (13) (14) . This modified model predicts that the Ca 2ϩ /CaM complex is required for activation of a tyrosine kinase that lies upstream of the GEF for Rac. Thus, most (see below) Ca 2ϩ /CaM antagonists block activation of Pak (Figs. 1 and 2) by preventing activation of Rac (Fig. 4) . Activation of the Src-related kinase Lyn by a mechanism dependent upon Ca 2 /CaM has been described in macrophages (55) . This scheme can also explain why agonists that only increase intracellular Ca 2 in neutrophils (thapsigargin, ionophore A23187) do not trigger activation of Pak (1, 2, 4) because ␤␥-subunits of complex G proteins are also required to effectively activate PI 3-K and thus Rac in these cells. Activation of Tiam1, a GEF for Rac, is catalyzed by CaM-PK and blocked by KN-93 in fibroblasts (42) . The inability of KN-93 to block activation of Rac in fMLP-stimulated neutrophils (Fig. 4D) suggests that Tiam1 is either not involved in this reaction in neutrophils or its activation under these circumstances does not require CaM-PK.
In contrast to studies reported in this paper and elsewhere (33, 44) , a previous paper has reported that activation of Rac in human neutrophils is insensitive to an antagonist of PI 3-K (10 M LY294002) and genistein (45) . The "pull-down" assay used to monitor activated Rac only measures the fraction of this GTPase that is accessible to the fusion protein and may not detect membrane associated Rac or Rac that forms high affinity complexes with other effector proteins (44) . Differences in assay conditions (e.g., detergents, incubation times) can alter the amount of "protected Rac" and could account for some of the discrepancies in the literature. A corollary of this situation is that the pull-down assay for Rac and the renaturation assay for Pak may monitor different populations of Rac.
It is noteworthy that KN-93, but not KN-92, blocked activation of the Paks in neutrophils (Fig. 2D ) but did not effect the activation of Rac (Fig. 4D) or O 2 Ϫ release (see Results). Thus, KN-93 blocks activation of Pak by a mechanism different from that of W-7 and TFP. KN-93 does not bind to CaM but competes for the CaM binding site on CaM-PK (40) . The concentrations of KN-93 that blocked activation of Paks (Fig. 2) were similar to those that inhibit CaM-PK in other cell types (40, 42) . The question as to whether a CaM-PK may be involved in the activation of Pak (e.g., by direct phosphorylation?) is currently under investigation.
In summary, we provide evidence that the Ca 2 /CaM complex plays a major role in activation of the Paks and ERKs in neutrophils through stimulation of their upstream effectors Rac and Ras. Identifying the direct target(s) of CaM in these pathways may markedly increase our knowledge of the GEFs in neutrophils that control a variety of cellular responses.
